Sosei Group
Tokyo · Founded 1990
About Sosei Group
Sosei Group Corporation is an international biopharmaceutical company originating from Japan that discovers and develops innovative biopharmaceuticals for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. By utilizing their platform technologies - GPCR structure-based drug design platform technology, peptide platform technologies and nanotechnology - they have established a product pipeline with first/best in class potential. Through development and commercialization partnerships they have already delivered three medicines to the market (two COPD bronchodilators and an emergency contraceptive), which generate significant and stable revenue streams that enable further growth.
Company Facts
- Founded: 1990
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $265.0M
- Funding stage: IPO
- Last round: Grant (Dec 2021)
- Ticker: tyo:4565
- Website: sosei.comen
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/sosei-group-180086 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.